These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. In vitro isolation of a neutralization escape mutant of equine infectious anemia virus (EIAV). Rwambo PM; Issel CJ; Hussain KA; Montelaro RC Arch Virol; 1990; 111(3-4):275-80. PubMed ID: 1693846 [TBL] [Abstract][Full Text] [Related]
13. Antigenic mapping of the envelope proteins of equine infectious anemia virus: identification of a neutralization domain and a conserved region on glycoprotein 90. Hussain KA; Issel CJ; Schnorr KL; Rwambo PM; West M; Montelaro RC Arch Virol; 1988; 98(3-4):213-24. PubMed ID: 2450529 [TBL] [Abstract][Full Text] [Related]
14. Role of the host immune response in selection of equine infectious anemia virus variants. Carpenter S; Evans LH; Sevoian M; Chesebro B J Virol; 1987 Dec; 61(12):3783-9. PubMed ID: 2446008 [TBL] [Abstract][Full Text] [Related]
15. Novel and dynamic evolution of equine infectious anemia virus genomic quasispecies associated with sequential disease cycles in an experimentally infected pony. Leroux C; Issel CJ; Montelaro RC J Virol; 1997 Dec; 71(12):9627-39. PubMed ID: 9371627 [TBL] [Abstract][Full Text] [Related]
16. Structural proteins of equine infectious anemia virus and their antigenic activity. Nishimura M; Nakajima H Am J Vet Res; 1984 Jan; 45(1):5-10. PubMed ID: 6322625 [TBL] [Abstract][Full Text] [Related]
17. Specificity of serum neutralizing antibodies induced by transient immune suppression of inapparent carrier ponies infected with a neutralization-resistant equine infectious anemia virus envelope strain. Howe L; Craigo JK; Issel CJ; Montelaro RC J Gen Virol; 2005 Jan; 86(Pt 1):139-149. PubMed ID: 15604441 [TBL] [Abstract][Full Text] [Related]
18. Transient immune suppression of inapparent carriers infected with a principal neutralizing domain-deficient equine infectious anaemia virus induces neutralizing antibodies and lowers steady-state virus replication. Craigo JK; Leroux C; Howe L; Steckbeck JD; Cook SJ; Issel CJ; Montelaro RC J Gen Virol; 2002 Jun; 83(Pt 6):1353-1359. PubMed ID: 12029150 [TBL] [Abstract][Full Text] [Related]
19. Antigenic variation and lentivirus persistence: variations in envelope gene sequences during EIAV infection resemble changes reported for sequential isolates of HIV. Payne SL; Fang FD; Liu CP; Dhruva BR; Rwambo P; Issel CJ; Montelaro RC Virology; 1987 Dec; 161(2):321-31. PubMed ID: 2825406 [TBL] [Abstract][Full Text] [Related]
20. Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition. Tagmyer TL; Craigo JK; Cook SJ; Even DL; Issel CJ; Montelaro RC J Virol; 2008 Apr; 82(8):4052-63. PubMed ID: 18234792 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]